Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionAnti-ENPP3 antibody-drug conjugate
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationRenal cancer
Indication DetailsTreat renal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today